Agreement between patient-reported flares and clinically significant flare status in patients with rheumatoid arthritis in sustained remission: data from the ARCTIC REWIND trials
Authors:
- Karen HoltenKHKaren Holten
- Nina Paulshus SundlisæterNSNina Paulshus Sundlisæter
- Joseph SextonJSJoseph Sexton
- Kaja E KjørholtKKKaja E Kjørholt
- Lena Bugge NordbergLNLena Bugge Nordberg
- Ellen MoholtEMEllen Moholt
- Till UhligTUTill Uhlig
- Désirée van der HeijdeDHDésirée van der Heijde
- Daniel H SolomonDSDaniel H Solomon
- Espen A HaavardsholmEHEspen A Haavardsholm
- Siri LillegravenSLSiri Lillegraven
- Anna-Birgitte AgaAAAnna-Birgitte Aga
Open Access
Abstract
Objectives To explore the agreement between patient-reported flare status and clinically significant flare status in patients with rheumatoid arthritis (RA) in sustained remission. Method Patients with RA in remission for ≥12 months on stable treatment were included in the ARCTIC REWIND tapering trials and pooled 12-month data used in current analyses. Patient-reported flare status was assessed according to the Outcome Measures in Rheumatology flare questionnaire; ‘Are you having a flare of your RA at this time?’ (yes/no). A clinically significant flare was defined as a combination of Disease Activity Score (DAS) >1.6, increase in DAS of ≥0.6 and 2 swollen joints, or the rheumatologist and patient agreed that a clinically significant flare had occurred. Agreement coefficient, sensitivity, specificity and predictive values of patient-reported flare status with regard to clinically significant flare status were determined. Results Of 248 patients, 64% were women, age 56.1 (11.8) years, disease duration 4.1 (2.8–7.4) years, DAS 0.8 (0.3). 35% of patients reported a flare at least once, clinically significant flares were recorded in 21%. 48/53 clinically significant flares (91%) led to an intensification of disease-modifying antirheumatic drugss. In 621/682 (91%) visits, patient-reported and clinically significant flare status were in agreement, agreement coefficient 0.89. Sensitivity and specificity were both 91%, positive predictive value of patient-reported flare status 46% and negative predictive value 99%. Conclusion Among patients in sustained remission, patient-reported flare status was accurate in ruling out a clinically significant flare. About half of the patient-reported flares were assessed to be clinically significant. These findings support a potential for using patient-reported flare status in remote monitoring of patients with RA in sustained remission.Keywords
Funding Information
- South-Eastern Norway Regional Health Authority (2013103)
- Research Council of Norway (2012/2285)
- Olav Thon Foundation
- Foundation Dam (2020/FO293936)
This publication has 50 references indexed in Scilit:
- Effect of Half-Dose vs Stable-Dose Conventional Synthetic Disease-Modifying Antirheumatic Drugs on Disease Flares in Patients With Rheumatoid Arthritis in RemissionJAMA, 2021
- Tender Joint Count and Inflammatory Activity in Patients With Established Rheumatoid Arthritis: Results From a Longitudinal StudyArthritis Care & Research, 2018
- Experiences With Telehealth Followup in Patients With Rheumatoid Arthritis: A Qualitative Interview StudyArthritis Care & Research, 2018
- Tele‐Health Followup Strategy for Tight Control of Disease Activity in Rheumatoid Arthritis: Results of a Randomized Controlled TrialArthritis Care & Research, 2017
- Validation of FLARE‐RA, a Self‐Administered Tool to Detect Recent or Current Rheumatoid Arthritis FlareArthritis & Rheumatology, 2017
- Patient self-assessment of flare in rheumatoid arthritis: criterion and concurrent validity of the Flare instrumentClinical Rheumatology, 2014
- Measures of rheumatoid arthritis disease activity: Patient (PtGA) and Provider (PrGA) Global Assessment of Disease Activity, Disease Activity Score (DAS) and Disease Activity Score With 28‐Joint Counts (DAS28), Simplified Disease Activity Index (SDAI), Clinical Disease Activity Index (CDAI), Patient Activity Score (PAS) and Patient Activity Score‐II (PASII), Routine Assessment of Patient Index Data (RAPID), Rheumatoid Arthritis Disease Activity Index (RADAI) and Rheumatoid Arthritis Disease Activity Index‐5 (RADAI‐5), Chronic Arthritis Systemic Index (CASI), Patient‐Based Disease Activity Score With ESR (PDAS1) and Patient‐Based Disease Activity Score Without ESR (PDAS2), and Mean Overall Index for Rheumatoid Arthritis (MOI‐RA)Arthritis Care & Research, 2011
- Progression of radiologic damage in patients with rheumatoid arthritis in clinical remissionArthritis & Rheumatism, 2004
- Rheumatoid arthritis measures: Disease Activity Score (DAS), Disease Activity Score-28 (DAS28), Rapid Assessment of Disease Activity in Rheumatology (RADAR), and Rheumatoid Arthritis Disease Activity Index (RADAI)Arthritis & Rheumatism, 2003
- Development and validation of the european league against rheumatism response criteria for rheumatoid arthritis: Comparison with the preliminary american college of rheumatology and the world health organization/international league against rheumatism criteriaArthritis & Rheumatism, 1996